The biotech industry, much like any other sector, has been significantly impacted by the COVID-19 pandemic. The extraordinary boom in 2020 and 2021 led to an influx of investments and an unprecedented surge in innovations. However, as the world transitions into a post-pandemic era, the biotech
In response to a significant decrease in early-stage research spending, Evotec, a leading German company focusing on drug discovery and contract development and manufacturing (CDMO), is undertaking substantial strategic changes. Under the new leadership of CEO Christian Wojczewski, Evotec has
The pharmaceutical industry is undergoing a significant transformation driven by the integration of data analytics, reshaping various aspects such as drug discovery, clinical trials, supply chain management, and commercial strategies. This change is not just a trend but a necessity as the industry
The acquisition of Jnana Therapeutics by Otsuka Pharmaceutical for $800 million in cash marks a significant moment in the pharmaceutical industry. This bold move grants Otsuka access to Jnana's innovative drug discovery platform, along with their experimental medicine for treating
The FDA's recent approval of a new treatment for severe alopecia areata marks a significant advance in addressing this challenging condition. Deuruxolitinib, branded as Leqselvi and developed by Sun Pharmaceutical Industries, will now compete with existing treatments from Eli Lilly and Pfizer,
In a groundbreaking partnership aimed at revolutionary advancements in biopharmaceutical research, Pfizer and Evotec have joined forces to discover new therapeutics targeting metabolic and infectious diseases. Announced on July 10, 2024, this collaboration will leverage Evotec’s state-of-the-art r
